Hot Life Science Investor Mandate 3: Venture Capital Firm Seeking Clinical Stage Therapeutics

2 Oct

​A venture capital company with office on the east and west coasts of the United States is currently making investments out of its 1st $180 million fund and is capable of making investments ranging from $5-$20 million into selected companies. The firm has made both equity and convertible note investments and is looking to make 3-6 investments over the next 6-9 months. The firm is looking for companies located globally.

The firm is looking to invest in the Therapeutics space and is open to considering both small molecules and biologics. The firm is looking for companies in the clinical stage that are at least post proof of concept. The firm is generally open to all subsectors and indications including orphan diseases.

​The firm is looking for management teams with experience that are backed d by strong science and a solid strategy. The firm looks to act as a hands on investor generally taking a board seat following investment. The firm is open to investing in both private and publically held companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: